IL103917A - A system for insertion through the skin that contains acetylsalicylic acid and a process for its production - Google Patents

A system for insertion through the skin that contains acetylsalicylic acid and a process for its production

Info

Publication number
IL103917A
IL103917A IL10391792A IL10391792A IL103917A IL 103917 A IL103917 A IL 103917A IL 10391792 A IL10391792 A IL 10391792A IL 10391792 A IL10391792 A IL 10391792A IL 103917 A IL103917 A IL 103917A
Authority
IL
Israel
Prior art keywords
application system
acetylsalicylic acid
transdermal application
asa
acceptable salts
Prior art date
Application number
IL10391792A
Other languages
English (en)
Hebrew (he)
Other versions
IL103917A0 (en
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL103917A0 publication Critical patent/IL103917A0/xx
Publication of IL103917A publication Critical patent/IL103917A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IL10391792A 1991-12-20 1992-11-29 A system for insertion through the skin that contains acetylsalicylic acid and a process for its production IL103917A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4142483 1991-12-20

Publications (2)

Publication Number Publication Date
IL103917A0 IL103917A0 (en) 1993-04-04
IL103917A true IL103917A (en) 1996-09-12

Family

ID=6447817

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10391792A IL103917A (en) 1991-12-20 1992-11-29 A system for insertion through the skin that contains acetylsalicylic acid and a process for its production

Country Status (23)

Country Link
US (2) US6264978B1 (es)
EP (1) EP0617623B1 (es)
JP (1) JP3748270B2 (es)
KR (2) KR100267442B1 (es)
AT (1) ATE217528T1 (es)
AU (1) AU667067B2 (es)
CA (1) CA2125662C (es)
CZ (1) CZ285190B6 (es)
DE (2) DE4241128C2 (es)
DK (1) DK0617623T3 (es)
ES (1) ES2176197T3 (es)
FI (1) FI113838B (es)
HR (1) HRP921157A2 (es)
HU (1) HU221679B1 (es)
IL (1) IL103917A (es)
NO (1) NO306599B1 (es)
NZ (1) NZ246158A (es)
PT (1) PT617623E (es)
SI (1) SI9200312A (es)
SK (1) SK67094A3 (es)
WO (1) WO1993012799A1 (es)
YU (1) YU75093A (es)
ZA (1) ZA922814B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
WO1994013302A1 (de) * 1991-12-20 1994-06-23 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe
US6071896A (en) * 1992-06-16 2000-06-06 Gundersen Clinic, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
CZ149495A3 (en) * 1992-12-07 1996-03-13 Lohmann Therapie Syst Lts Transdermally administered system containing acetylsalicylic acid for antithrombotic therapy with cancer prophylaxis
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
WO1997004759A1 (en) * 1995-07-27 1997-02-13 Cal International Limited Transdermal patch containing aspirin
AU6708996A (en) * 1995-07-27 1997-02-26 Cal International Limited Transdermal nitrate formulation
AU6709096A (en) * 1995-07-27 1997-02-26 Cal International Limited Pharmaceutical preparation for percutaneous absorbtion
EP0784975B1 (en) * 1995-12-26 2005-10-19 Teikoku Seiyaku Kabushiki Kaisha Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries
DE19601487C2 (de) * 1996-01-17 2001-09-13 Micronas Gmbh Vorrichtung zum Behandeln von malignen Gewebsveränderungen
JPH1112177A (ja) 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
DE19949252B4 (de) * 1999-10-13 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung
JP2001187739A (ja) * 1999-12-28 2001-07-10 Teikoku Seiyaku Co Ltd アレルギー性皮膚疾患治療用外用剤
WO2003018023A1 (en) * 2001-08-23 2003-03-06 Bruce Frome Compositions and methods for targeting cerebral circulation and treatment of headache
US20040248858A1 (en) * 2003-06-09 2004-12-09 Parghi Kaumil H. Cure for cancer
US20060127463A1 (en) * 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
AU2006346195B2 (en) 2006-07-09 2013-03-07 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
MX2009011849A (es) * 2007-05-09 2009-11-13 Buckman Labor Inc Emulsiones de aprestacion de asa para papel y carton.
CA2691446C (en) * 2007-06-04 2021-07-06 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
EP2370406A4 (en) 2008-12-04 2014-02-19 Chongxi Yu COMPOSITIONS WITH HIGH PENETRATION AND ITS APPLICATIONS
WO2011076401A1 (de) 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen
JP6445967B2 (ja) 2012-01-18 2018-12-26 テックフィールズ ファーマ カンパニー リミテッド 肺疾患の治療のための高浸透性プロドラッグ組成物およびその薬学的組成物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
FR2297612A1 (fr) 1975-01-20 1976-08-13 Moorleghem Guy Van Procede de fabrication d'un produit analgesique a usage externe
US4012508A (en) 1975-02-03 1977-03-15 Burton Verna M Topical composition and method
US4219548A (en) 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
FR2496459A1 (fr) 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
US4460368A (en) * 1981-10-29 1984-07-17 Almedco, Inc. Trans-dermal medication system
IL68965A (en) 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
EP0162239B1 (en) 1984-04-23 1991-08-07 Kao Corporation Percutaneous absorption accelerator and preparation containing same
JPS61167615A (ja) 1985-01-18 1986-07-29 Teisan Seiyaku Kk 薬剤投与方法
US4810699A (en) 1987-02-20 1989-03-07 American Home Products Corporation Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
JPH01203336A (ja) 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
JPH01242521A (ja) 1988-03-23 1989-09-27 Nikko Kemikaruzu Kk 経皮吸収性を高めた消炎鎮痛薬組成物
US4975269A (en) 1989-07-31 1990-12-04 Leonard Chavkin Shelf stable aspirin solutions
CA2107587C (en) * 1991-04-03 2004-11-23 Rudolph M. Kiemowitz Suppression of thromboxane levels by percutaneous administration of aspirin

Also Published As

Publication number Publication date
CZ285190B6 (cs) 1999-06-16
FI942922A0 (fi) 1994-06-17
WO1993012799A1 (de) 1993-07-08
FI113838B (fi) 2004-06-30
FI942922A (fi) 1994-06-17
JP3748270B2 (ja) 2006-02-22
ZA922814B (en) 1993-06-23
EP0617623B1 (de) 2002-05-15
ES2176197T3 (es) 2002-12-01
AU3158993A (en) 1993-07-28
HRP921157A2 (en) 1994-10-31
ATE217528T1 (de) 2002-06-15
NO942325L (no) 1994-06-17
SK67094A3 (en) 1995-03-08
HU9401849D0 (en) 1994-09-28
EP0617623A1 (de) 1994-10-05
DK0617623T3 (da) 2002-09-09
DE59209956D1 (de) 2002-06-20
KR950703972A (ko) 1995-11-17
YU75093A (sh) 1997-08-22
CZ145694A3 (en) 1995-01-18
NO942325D0 (no) 1994-06-17
JPH07502521A (ja) 1995-03-16
KR100267442B1 (ko) 2000-11-01
DE4241128A1 (en) 1993-06-24
AU667067B2 (en) 1996-03-07
NZ246158A (en) 1995-10-26
SI9200312A (en) 1993-06-30
DE4241128C2 (de) 1996-05-23
HUT74559A (en) 1997-01-28
HU221679B1 (hu) 2002-12-28
CA2125662A1 (en) 1993-07-08
PT617623E (pt) 2002-10-31
CA2125662C (en) 2006-10-17
KR100267359B1 (ko) 2000-11-01
NO306599B1 (no) 1999-11-29
US6264978B1 (en) 2001-07-24
IL103917A0 (en) 1993-04-04
US5861170A (en) 1999-01-19

Similar Documents

Publication Publication Date Title
US5861170A (en) Acetylsalicyclic acid-containing transdermal application system for antithrombotic therapy
US4696821A (en) Transdermal delivery system for administration of nitroglycerin
EP1158967B1 (en) Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix
US4788064A (en) Transdermal delivery system
KR20000000640A (ko) 비-스테로이드성 소염 진통제의 경피흡수투여용조성물 및 이를포함하는 경피흡수투여용 제형
JP3799502B2 (ja) 抗血栓治療および癌予防のためのアセチルサリチル酸を含有する経皮投与システム
Alhamdany et al. Transdermal patch of acetylsalicylic acid as an alternative dosage form: A review
SI9400023A (sl) Transdermalni sistem dajanja, vsebujoč acetilsalicilno kislino za antitrombotsko terapijo in profilakso proti raku
WO1994013302A1 (de) Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe
IE960539A1 (en) Pharmaceutical preparation for percutaneous absorbtion
Umesh Development and evaluation of transdermal drug delivery system of antihyperlipidemic agent
JPH07157432A (ja) 貼付剤
KR20000000822A (ko) 알쯔하이머성 치매치료용 경피흡수제제

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees